Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota

Aggeletopoulou, 2019, The role of the gut microbiota in the treatment of inflammatory bowel diseases, Microb. Pathog., 137, 10.1016/j.micpath.2019.103774 Ananthakrishnan, 2015, Epidemiology and risk factors for IBD, Nat. Rev. Gastroenterol. Hepatol., 12, 205, 10.1038/nrgastro.2015.34 Andoh, 2003, Role of dietary fiber and short-chain fatty acids in the colon, Curr. Pharmaceut. Des., 9, 347, 10.2174/1381612033391973 Barcelo, 2000, Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon, Gut, 46, 218, 10.1136/gut.46.2.218 Botticelli, 2017, Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment, Oncotarget, 8, 8890, 10.18632/oncotarget.12985 Chelakkot, 2018, Mechanisms regulating intestinal barrier integrity and its pathological implications, Exp. Mol. Med., 50, 1, 10.1038/s12276-018-0126-x Clavel, 2017, Deciphering interactions between the gut microbiota and the immune system via microbial cultivation and minimal microbiomes, Immunol. Rev., 279, 8, 10.1111/imr.12578 Cohen, 2019, Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases, Gastroenterology, 156, 2174, 10.1053/j.gastro.2019.03.017 Dasu, 2008, High glucose induces toll-like receptor expression in human monocytes: mechanism of activation, Diabetes, 57, 3090, 10.2337/db08-0564 Eeckhaut, 2013, Butyricicoccus pullicaecorum in inflammatory bowel disease, Gut, 62, 1745, 10.1136/gutjnl-2012-303611 Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766 Frank, 2011, Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases, Inflamm. Bowel Dis., 17, 179, 10.1002/ibd.21339 Garten, 2009, Nampt: linking NAD biology, metabolism and cancer, Trends Endocrinol. Metabol., 20, 130, 10.1016/j.tem.2008.10.004 Goverse, 2017, Diet-Derived short chain fatty acids stimulate intestinal epithelial cells to induce mucosal tolerogenic dendritic cells, J. Immunol., 198, 2172, 10.4049/jimmunol.1600165 Green-Johnson, 2012, Immunological responses to gut bacteria, J. AOAC Int., 95, 35, 10.5740/jaoacint.SGE_Green-Johnson Han, 2015, Sodium butyrate protects the intestinal barrier function in peritonitic mice, Int. J. Clin. Exp. Med., 8, 4000 Huang, 2021, NMN maintains intestinal homeostasis by regulating the gut microbiota, Front. Nutr., 8, 10.3389/fnut.2021.714604 Imai, 2009, The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance, Cell Biochem. Biophys., 53, 65, 10.1007/s12013-008-9041-4 Lee, 2015, Diet in the pathogenesis and treatment of inflammatory bowel diseases, Gastroenterology, 148, 1087, 10.1053/j.gastro.2015.01.007 Li, 2019, Targeting Gut Microbiota for the Prevention and Management of Diabetes Mellitus by Dietary Natural Products, 8, 440 Li, 2022, Exploring the phytochemicals and inhibitory effects against α-glucosidase and dipeptidyl peptidase-IV in Chinese pickled chili pepper: insights into mechanisms by molecular docking analysis, LWT, 162, 10.1016/j.lwt.2022.113467 Manichanh, 2006, Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach, Gut, 55, 205, 10.1136/gut.2005.073817 McCoy, 2017, Host-microbiota interactions and adaptive immunity, Immunol. Rev., 279, 63, 10.1111/imr.12575 Moghadamrad, 2015, Attenuated portal hypertension in germ-free mice: function of bacterial flora on the development of mesenteric lymphatic and blood vessels, Hepatology, 61, 1685, 10.1002/hep.27698 Nastasi, 2015, The effect of short-chain fatty acids on human monocyte-derived dendritic cells, Sci. Rep., 5, 10.1038/srep16148 Peng, 2019, Vitexin ameliorates high fat diet-induced obesity in male C57BL/6J mice via the AMPKα-mediated pathway, Food Funct., 10, 1940, 10.1039/C9FO00148D Poddar, 2019, Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule, Biomolecules, 9, 10.3390/biom9010034 Pryde, 2002, The microbiology of butyrate formation in the human colon, FEMS Microbiol. Lett., 217, 133, 10.1111/j.1574-6968.2002.tb11467.x Rooks, 2016, Gut microbiota, metabolites and host immunity, Nat. Rev. Immunol., 16, 341, 10.1038/nri.2016.42 Schroeder, 2016, Signals from the gut microbiota to distant organs in physiology and disease, Nat. Med., 22, 1079, 10.1038/nm.4185 Shang, 2022, Analysis of phenolic compounds in pickled chayote and their effects on antioxidant activities and cell protection, Food Res. Int., 157, 10.1016/j.foodres.2022.111325 Shen, 2019, The clinicopathological significance of ubiquitin-conjugating enzyme E2C, leucine-rich repeated-containing G protein-coupled receptor, WW domain-containing oxidoreductase, and vasculogenic mimicry in invasive breast carcinoma, Medicine (Baltim.), 98 Vetizou, 2018, Anti-PD1 in the wonder-gut-land, Cell Res., 28, 263, 10.1038/cr.2018.12 Vieira, 2015, A role for gut microbiota and the metabolite-sensing receptor GPR43 in a murine model of gout, Arthritis Rheumatol., 67, 1646, 10.1002/art.39107 Wang, 2020, A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice, Gut, 69, 1988, 10.1136/gutjnl-2019-320105 Wang, 2016, Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death, Brain Res., 1643, 1, 10.1016/j.brainres.2016.04.060 Yamamoto, 2014, Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion, PLoS One, 9, 10.1371/journal.pone.0098972 Yanagibashi, 2013, IgA production in the large intestine is modulated by a different mechanism than in the small intestine: Bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA+ B cells, Immunobiology, 218, 645, 10.1016/j.imbio.2012.07.033 Yoshino, 2011, Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice, Cell Metabol., 14, 528, 10.1016/j.cmet.2011.08.014